Procurement Summary
Country: USA
Summary: Immune Mechanisms of Protection against Mycobacterium Tuberculosis Center Impactb
Deadline: 02 Jun 2026
Posting Date: 19 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141551886
Document Ref. No.: BAA-75N93026R00008
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Introduction
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. NIAID supports a robust program in basic immunology that includes detailed analyses of human immune responses to pathogenic infections and/or vaccines. NIAID also has a key role in basic, translational and clinical studies to further the understanding of Mycobacterium tuberculosis infection and disease in people living with or without HIV. Furthermore, NIAID provides several resources to the scientific community including testing services of therapeutics, animal models, reagents for research to support biomedical drug, vaccines and diagnostics research.
The NIAID Divisions of AIDS (DAIDS); Allergy Immunology and Transplantation (DAIT) and Microbiology and Infectious Diseases (DMID) have a joint requirement for the continued support of the Immune Mechanisms of Protection against Mycobacterium tuberculosis center (IMPAc-TB) program to accelerate TB vaccine development through characterization of protective tissue-specific and systemic immune responses that prevent or contain Mtb infection and the advancement of tools and resources to support TB vaccine development. The objective of the IMPAc-TB program renewal is to address these knowledge gaps and accelerate TB vaccine development by supporting research that further characterizes both tissue-specific and systemic protective immune responses, that prevent or contain Mtb infection, and furthers the advancement of tools and resources that facilitate TB vaccine development (e.g., biological models and in vitro systems, computational and modeling platforms). This program will continue to support the co...
Notice ID: baa-75n93026r00008
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health niaid
Product Service Code: an12 - health r&d services; health care services; applied research
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Inactive Dates: jun 17, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip